Nov 11 (Reuters) – Pfizer said on Wednesday Blackstone would provide up to $1.5 billion through 2028 to help fund the development of its experimental monthly obesity treatment.
(Reporting by Kunal Das in Bengaluru; Editing by Leroy Leo)
